Riverain Technologies
Revolutionizing chest imaging interpretation with Clear Visual Intelligence™ solutions that improve the detection, diagnosis, and management of lung diseases.
Company Overview
Riverain Technologies is a medical device business aimed to revolutionize chest imaging interpretation. Their Clear Visual Intelligence™ solutions improve the detection, diagnosis, and management of lung diseases. They are on a mission to eliminate delayed cardiothoracic disease diagnoses.
The ClearRead™ technologies provide an unimpaired view that enables the radiologist to focus on the actionable data in chest imaging to more precisely detect, characterize, and report findings to improve diagnostic accuracy and efficiency.
Founded in 2004, Riverain Technologies’ roots trace back as the pioneers in chest X-ray CAD. In the years that followed, the company continued to innovate with patents in chest X-ray bone suppression and chest CT vessel suppression.
Today, ClearRead CT and ClearRead Xray offer solution suites that improve visibility of chest images, improve the detection of nodules, and optimize detection of cardiothoracic diseases.
Modalities
Subspecialities
Applications available
ClearRead™ CT with Clear Visual Intelligence™
Detection of pulmonary nodules by suppressing vessels and machine noise.
CE
FDA
UKCA
tga
MDALL
MedSafe
HSA
CT
Pulmonology
ClearRead™ Xray with Clear Visual Intelligence™
Detection of cardiothoracic diseases by suppressing bones and machine noise.
FDA
CE
MDALL
SwissMedic
XR
Pulmonology
To find out more about Riverain Technologies’s solutions, or the 100+ other applications on the Blackford Platform, book a discovery call with our team.
Book a meeting
We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.
Book a Meeting